Rosane Orofino-Costa1, Dayvison Francis Saraiva Freitas2, Andréa Reis Bernardes-Engemann3, Anderson Messias Rodrigues4, Carolina Talhari5, Claudia Elise Ferraz6, John Verrinder Veasey7, Leonardo Quintella2, Maria Silvia Laborne Alves de Sousa8, Rodrigo Vettorato9, Rodrigo de Almeida-Paes2, Priscila Marques de Macedo10. 1. Dermatology Department, University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Department of Mycology, Brazilian Society of Dermatology, Rio de Janeiro, RJ, Brazil. Electronic address: rosaneorofino@icloud.com. 2. Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil. 3. Dermatology Department, University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil. 4. Discipline of Cell Biology, Federal University of São Paulo, São Paulo, SP, Brazil. 5. Health School, University of Amazon State, Manaus, AM, Brazil. 6. Health Science Center, Federal University of Pernambuco, Recife, PE, Brazil. 7. Department of Mycology, Brazilian Society of Dermatology, Rio de Janeiro, RJ, Brazil; Faculty of Medical Sciences, Santa Casa de Misericórdia, São Paulo, SP, Brazil. 8. Dermatology Clinic, Santa Casa de Misericórdia, Belo Horizonte, MG, Brazil. 9. Department of Dermatology, Santa Casa de Misericórdia, Porto Alegre, RS, Brazil. 10. Department of Mycology, Brazilian Society of Dermatology, Rio de Janeiro, RJ, Brazil; Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil.
Abstract
BACKGROUND: The increase in the zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis, which started in the late 1990s in Rio de Janeiro and is now found in almost all Brazilian states, has been equally advancing in neighboring countries of Brazil. Changes in the clinical-epidemiological profile, advances in the laboratory diagnosis of the disease, and therapeutic difficulties have been observed throughout these almost 25 years of the epidemic, although there is no national consensus. The last international guideline dates from 2007. OBJECTIVES: Update the clinical classification, diagnostic methods and recommendations on the therapeutic management of patients with sporotrichosis. METHODS: Twelve experts in human sporotrichosis were selected from different Brazilian regions, and divided into three work groups: clinical, diagnosis and treatment. The bibliographic research was carried out on the EBSCOHost platform. Meetings took place via electronic mail and remote/face-to-face and hybrid settings, resulting in a questionnaire which pointed out 13 divergences, resolved based on the opinion of the majority of the participants. RESULTS: The clinical classification and laboratory diagnosis were updated. Therapeutic recommendations were made for the different clinical forms. CONCLUSION: Publication of the first national recommendation, carried out by the Brazilian Society of Dermatology, aimed at the Brazilian scientific community, especially dermatologists, infectologists, pediatricians, family medicine personnel, and laboratory professionals who work in the management of human sporotrichosis.
BACKGROUND: The increase in the zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis, which started in the late 1990s in Rio de Janeiro and is now found in almost all Brazilian states, has been equally advancing in neighboring countries of Brazil. Changes in the clinical-epidemiological profile, advances in the laboratory diagnosis of the disease, and therapeutic difficulties have been observed throughout these almost 25 years of the epidemic, although there is no national consensus. The last international guideline dates from 2007. OBJECTIVES: Update the clinical classification, diagnostic methods and recommendations on the therapeutic management of patients with sporotrichosis. METHODS: Twelve experts in human sporotrichosis were selected from different Brazilian regions, and divided into three work groups: clinical, diagnosis and treatment. The bibliographic research was carried out on the EBSCOHost platform. Meetings took place via electronic mail and remote/face-to-face and hybrid settings, resulting in a questionnaire which pointed out 13 divergences, resolved based on the opinion of the majority of the participants. RESULTS: The clinical classification and laboratory diagnosis were updated. Therapeutic recommendations were made for the different clinical forms. CONCLUSION: Publication of the first national recommendation, carried out by the Brazilian Society of Dermatology, aimed at the Brazilian scientific community, especially dermatologists, infectologists, pediatricians, family medicine personnel, and laboratory professionals who work in the management of human sporotrichosis.
Authors: A Bonifaz; A Tirado-Sánchez; V Paredes-Solís; R Cepeda-Valdés; G M González; R J Treviño-Rangel; L Fierro-Arias Journal: J Eur Acad Dermatol Venereol Date: 2017-09-19 Impact factor: 6.166
Authors: Tânia Maria Pacheco Schubach; Armando de Oliveira Schubach; Rosani Santos dos Reis; Tullia Cuzzi-Maya; Tânia Cristina Moita Blanco; Dilma Ferreira Monteiro; Bastos Mĵnica de Lima Barros; Ricardo Brustein; Rosely Maria Zancopé-Oliveira; Paulo Cezar Fialho Monteiro; Bodo Wanke Journal: Mycopathologia Date: 2002 Impact factor: 2.574
Authors: Florencia D Rojas; Mariana S Fernández; Juan Manuel Lucchelli; Dora Lombardi; José Malet; María Eugenia Vetrisano; María Emilia Cattana; María de Los Ángeles Sosa; Gustavo Giusiano Journal: Mycopathologia Date: 2017-10-23 Impact factor: 2.574
Authors: A C Procópio-Azevedo; V B S Rabello; M M Muniz; M H G Figueiredo-Carvalho; R Almeida-Paes; R M Zancopé-Oliveira; J C A L Silva; P M de Macedo; A C F Valle; M C Gutierrez-Galhardo; D F S Freitas Journal: Br J Dermatol Date: 2021-09-30 Impact factor: 9.302
Authors: João Eudes Filho; Isabele Barbieri Dos Santos; Carmélia Matos Santiago Reis; José Salvatore Leister Patané; Verenice Paredes; João Paulo Romualdo Alarcão Bernardes; Sabrina Dos Santos Costa Poggiani; Talita de Cássia Borges Castro; Oscar Mauricio Gomez; Sandro Antonio Pereira; Edvar Yuri Pacheco Schubach; Kamila Peres Gomes; Heidi Mavengere; Lucas Gomes de Brito Alves; Joaquim Lucas; Hugo Costa Paes; Patrícia Albuquerque; Laurício Monteiro Cruz; Juan G McEwen; Jason E Stajich; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira; Daniel R Matute; Bridget M Barker; Maria Sueli Soares Felipe; Marcus de Melo Teixeira; André Moraes Nicola Journal: Emerg Microbes Infect Date: 2020-12 Impact factor: 7.163